Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges

Amps, 2011, Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage, Nat. Biotechnol., 29, 1132, 10.1038/nbt.2051 Araki, 2013, Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells, Nature, 494, 100, 10.1038/nature11807 Araki, 2020, Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency, Nat. Commun., 11, 197, 10.1038/s41467-019-13830-x Aron Badin, 2019, MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates, Nat. Commun., 10, 4357, 10.1038/s41467-019-12324-0 Avior, 2019, Cancer-Related Mutations Identified in Primed and Naive Human Pluripotent Stem Cells, Cell Stem Cell, 25, 456, 10.1016/j.stem.2019.09.001 Bradley, 1984, Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines, Nature, 309, 255, 10.1038/309255a0 Brons, 2007, Derivation of pluripotent epiblast stem cells from mammalian embryos, Nature, 448, 191, 10.1038/nature05950 Campbell, 1996, Sheep cloned by nuclear transfer from a cultured cell line, Nature, 380, 64, 10.1038/380064a0 Carson, 2006, CNS immune privilege: hiding in plain sight, Immunol. Rev., 213, 48, 10.1111/j.1600-065X.2006.00441.x Choi, 2015, A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs, Nat. Biotechnol., 33, 1173, 10.1038/nbt.3388 Cornacchia, 2019, Lipid Deprivation Induces a Stable, Naive-to-Primed Intermediate State of Pluripotency in Human PSCs, Cell Stem Cell, 25, 120, 10.1016/j.stem.2019.05.001 Deuse, 2019, De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans, Nat. Biotechnol., 37, 1137, 10.1038/s41587-019-0227-7 Di Stefano, 2018, Reduced MEK inhibition preserves genomic stability in naive human embryonic stem cells, Nat. Methods, 15, 732, 10.1038/s41592-018-0104-1 Dullens, 2020, Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines, J. Oncol., 2020, 9873954 Eggington, 2014, A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes, Clin. Genet., 86, 229, 10.1111/cge.12315 Gore, 2011, Somatic coding mutations in human induced pluripotent stem cells, Nature, 471, 63, 10.1038/nature09805 Gornalusse, 2017, HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells, Nat. Biotechnol., 35, 765, 10.1038/nbt.3860 Guha, 2013, Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells, Cell Stem Cell, 12, 407, 10.1016/j.stem.2013.01.006 Hayashi, 2017, Coordinated generation of multiple ocular-like cell lineages and fabrication of functional corneal epithelial cell sheets from human iPS cells, Nat. Protoc., 12, 683, 10.1038/nprot.2017.007 Hayashi, 2018, CD200 facilitates the isolation of corneal epithelial cells derived from human pluripotent stem cells, Sci. Rep., 8, 16550, 10.1038/s41598-018-34845-2 Hong, 2009, Suppression of induced pluripotent stem cell generation by the p53-p21 pathway, Nature, 460, 1132, 10.1038/nature08235 Hwang, 2004, Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst, Science, 303, 1669, 10.1126/science.1094515 Ichise, 2017, NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs, Stem Cell Reports, 9, 853, 10.1016/j.stemcr.2017.07.020 Ilic, 2017, Concise Review: Human Embryonic Stem Cells-What Have We Done? What Are We Doing? Where Are We Going?, Stem Cells, 35, 17, 10.1002/stem.2450 Ji, 2012, Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells, Stem Cells, 30, 435, 10.1002/stem.1011 Kajiwara, 2012, Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells, Proc. Natl. Acad. Sci. USA, 109, 12538, 10.1073/pnas.1209979109 Kattman, 2011, Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines, Cell Stem Cell, 8, 228, 10.1016/j.stem.2010.12.008 Kawamura, 2016, Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates, Stem Cell Reports, 6, 312, 10.1016/j.stemcr.2016.01.012 Kikuchi, 2017, Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model, Nature, 548, 592, 10.1038/nature23664 Kojima, 2019, Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury, Stem Cells Transl. Med., 8, 260, 10.1002/sctm.18-0096 Kosicki, 2018, Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements, Nat. Biotechnol., 36, 765, 10.1038/nbt.4192 Koyanagi-Aoi, 2013, Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells, Proc. Natl. Acad. Sci. USA, 110, 20569, 10.1073/pnas.1319061110 Kunitomi, 2016, H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells, Stem Cell Reports, 6, 825, 10.1016/j.stemcr.2016.04.015 Kwon, 2017, iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations, Proc. Natl. Acad. Sci. USA, 114, 1964, 10.1073/pnas.1616035114 Lanza, 2019, Engineering universal cells that evade immune detection, Nat. Rev. Immunol., 19, 723, 10.1038/s41577-019-0200-1 Li, 2016, Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain, Proc. Natl. Acad. Sci. USA, 113, 6544, 10.1073/pnas.1605245113 Lo Sardo, 2017, Influence of donor age on induced pluripotent stem cells, Nat. Biotechnol., 35, 69, 10.1038/nbt.3749 Malchenko, 2014, Onset of rosette formation during spontaneous neural differentiation of hESC and hiPSC colonies, Gene, 534, 400, 10.1016/j.gene.2013.07.101 Mandai, 2017, Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration, N. Engl. J. Med., 376, 1038, 10.1056/NEJMoa1608368 Martincorena, 2015, Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin, Science, 348, 880, 10.1126/science.aaa6806 Merkle, 2017, Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations, Nature, 545, 229, 10.1038/nature22312 Morizane, 2017, MHC matching improves engraftment of iPSC-derived neurons in non-human primates, Nat. Commun., 8, 385, 10.1038/s41467-017-00926-5 Mosquera Orgueira, 2020, Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome, Sci. Rep., 10, 2407, 10.1038/s41598-020-59243-5 Nakamura, 2013, Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells, Cell Res., 23, 70, 10.1038/cr.2012.171 Nakatsuji, 2008, HLA-haplotype banking and iPS cells, Nat. Biotechnol., 26, 739, 10.1038/nbt0708-739 Nishizawa, 2016, Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity, Cell Stem Cell, 19, 341, 10.1016/j.stem.2016.06.019 Okita, 2007, Generation of germline-competent induced pluripotent stem cells, Nature, 448, 313, 10.1038/nature05934 Okita, 2008, Generation of mouse induced pluripotent stem cells without viral vectors, Science, 322, 949, 10.1126/science.1164270 Okubo, 2016, Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury, Stem Cell Reports, 7, 649, 10.1016/j.stemcr.2016.08.015 Osafune, 2008, Marked differences in differentiation propensity among human embryonic stem cell lines, Nat. Biotechnol., 26, 313, 10.1038/nbt1383 Peshkin, 2001, BRCA1/2 testing: complex themes in result interpretation, J. Clin. Oncol., 19, 2555, 10.1200/JCO.2001.19.9.2555 Rouhani, 2016, Mutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells, PLoS Genet., 12, e1005932, 10.1371/journal.pgen.1005932 Sato, 2019, Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider, Cytotherapy, 21, 1095, 10.1016/j.jcyt.2019.10.001 Sharma, 2019, Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs, Sci. Transl. Med., 11, eaat5580, 10.1126/scitranslmed.aat5580 Sondka, 2018, The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers, Nat. Rev. Cancer, 18, 696, 10.1038/s41568-018-0060-1 Sougawa, 2018, Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy, Sci. Rep., 8, 3726, 10.1038/s41598-018-21923-8 Sugita, 2016, Successful Transplantation of Retinal Pigment Epithelial Cells from MHC Homozygote iPSCs in MHC-Matched Models, Stem Cell Reports, 7, 635, 10.1016/j.stemcr.2016.08.010 Sugita, 2020, HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration, J. Clin. Med., 9, 2217, 10.3390/jcm9072217 Supek, 2014, Synonymous mutations frequently act as driver mutations in human cancers, Cell, 156, 1324, 10.1016/j.cell.2014.01.051 Tachibana, 2013, Human embryonic stem cells derived by somatic cell nuclear transfer, Cell, 153, 1228, 10.1016/j.cell.2013.05.006 Tada, 2001, Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells, Curr. Biol., 11, 1553, 10.1016/S0960-9822(01)00459-6 Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 Takashima, 2014, Resetting transcription factor control circuitry toward ground-state pluripotency in human, Cell, 158, 1254, 10.1016/j.cell.2014.08.029 Taylor, 2016, Ocular Immune Privilege and Transplantation, Front. Immunol., 7, 37, 10.3389/fimmu.2016.00037 Taylor, 2005, Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching, Lancet, 366, 2019, 10.1016/S0140-6736(05)67813-0 Tesar, 2007, New cell lines from mouse epiblast share defining features with human embryonic stem cells, Nature, 448, 196, 10.1038/nature05972 Theunissen, 2016, Molecular Criteria for Defining the Naive Human Pluripotent State, Cell Stem Cell, 19, 502, 10.1016/j.stem.2016.06.011 Theunissen, 2014, Systematic identification of culture conditions for induction and maintenance of naive human pluripotency, Cell Stem Cell, 15, 471, 10.1016/j.stem.2014.07.002 Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 Umekage, 2019, Overview: an iPS cell stock at CiRA, Inflamm. Regen., 39, 17, 10.1186/s41232-019-0106-0 Xu, 2019, Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility, Cell Stem Cell, 24, 566, 10.1016/j.stem.2019.02.005 Yamanaka, 2012, Induced pluripotent stem cells: past, present, and future, Cell Stem Cell, 10, 678, 10.1016/j.stem.2012.05.005 Ying, 2008, The ground state of embryonic stem cell self-renewal, Nature, 453, 519, 10.1038/nature06968 Yokoyama, 2019, Age-related remodelling of oesophageal epithelia by mutated cancer drivers, Nature, 565, 312, 10.1038/s41586-018-0811-x Young, 2012, Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells, Cell Stem Cell, 10, 570, 10.1016/j.stem.2012.03.002 Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 Zhao, 2011, Immunogenicity of induced pluripotent stem cells, Nature, 474, 212, 10.1038/nature10135